lobbying_activities: 2826500

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2826500	dc00256f-0827-4048-805e-d832bb40b186	Q2	KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)	401105192	CVS HEALTH	2022	second_quarter	PHA	Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs. Issues related to the continuation of prescription drug access and testing during COVID crisis. Issues related to Medicare Part D rebates.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2022-07-18T20:49:22-04:00